45 results
Cryptogenic Organizing Pneumonia (COP)

Cryptogenic Organizing Pneumonia Overview:
 • Idiopathic form of organizing pneumonia
 • formerly BOOP
Pneumonia (COP) ... - No specific lab ... Anti-dsDNA, ANCA COP ... Organizing Pneumonia Treatment ... Organizing #Pneumonia #COP
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Algorithm for Chronic ... pulmonary disease (COPD ... corticosteroid; LABA ... #COPD #Treatment ... #Algorithm #Management
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... algorithms by Global ... indicate preferred treatment ... Management #Pulmonary #COPD ... #LABA #ICS #Guidelines
COPD Preferred Treatments - GOLD 2018 

COPD is a common progressive respiratory condition that can be
COPD Preferred Treatments ... GOLD 2018 COPD ... Management of COPD ... inhalers that include LABA ... #Treatment #Management
Long-Acting Dual Bronchodilators - LAMA/LABA Combo Inhalers 

The FDA approved a new dual bronchodilator (LABA/LAMA) combination
/LABA Combo Inhalers ... is approved for treatment ... of COPD These ... recommended regimens for COPD ... #LABA #Combo #Inhalers
First-line therapies for Asthma, Asthma-COPD Overlap and COPD

The diagnosis of COPD, asthma, and ACO initially requires
Overlap and COPD ... corticosteroids; LABA ... long-acting β2-agonist; LAMA ... #Differences #Algorithm ... #Treatment
The 2019 Global Initiative for Asthma (GINA) treatment strategy figure for adults and adolescents, annotated to
Asthma (GINA) treatment ... corticosteroids; SABA ... receptor antagonists; LABA ... Pulmonary #StepUp #Treatment ... #Algorithm #Guidelines
Chronic Obstructive Pulmonary Disease (COPD)
 • COPD Definition
 • Role of PFTs
 • COPD Classification and
Pulmonary Disease (COPD ... ) • COPD Definition ... Role of PFTs • COPD ... Group Assessment (ABCD ... management #GOLD2022 #treatment
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Reduce risk of COPD ... /LABA/ICS) - ... /LABA) & Eosinophils ... recommendations for the treatment ... of COPD.
Cryptogenic Organizing Pneumonia - Illness Script

PATHOPHYSIOLOGY: Unknown trigger, reversible inflammatory/fibroproliferative process. Polypoid fibroblastic aggregates that plug
Cryptogenic Organizing ... No secondary OP ... , neoplastic) TREATMENT ... TylerLarsenMD #COP ... #Cryptogenic #Organizing